P
Peter C. Taylor
Researcher at University of Oxford
Publications - 397
Citations - 19020
Peter C. Taylor is an academic researcher from University of Oxford. The author has contributed to research in topics: Rheumatoid arthritis & Arthritis. The author has an hindex of 63, co-authored 359 publications receiving 16347 citations. Previous affiliations of Peter C. Taylor include HealthPartners & University of Cambridge.
Papers
More filters
Journal ArticleDOI
Plasma Levels of Eicosapentaenoic Acid Are Associated with Anti-TNF Responsiveness in Rheumatoid Arthritis and Inhibit the Etanercept-driven Rise in Th17 Cell Differentiation in Vitro.
Louisa E. Jeffery,Helena L. Fisk,Philip C. Calder,A Filer,Karim Raza,Christopher D. Buckley,Iain B. McInnes,Peter C. Taylor,Benjamin A Fisher +8 more
TL;DR: EPA status was associated with clinical improvements to anti-TNF therapy in vivo and prevented the effect of ETN on Th17 cells in vitro, suggesting that EPA supplementation might be a simple way to improve anti- TNF outcomes in patients with RA by suppressing Th17 frequencies.
Journal ArticleDOI
The down-regulation of IL1alpha and IL6, in monocytes exposed to extracorporeal photopheresis (ECP)-treated lymphocytes, is not dependent on lymphocyte phosphatidylserine externalization.
John Bladon,Peter C. Taylor +1 more
TL;DR: ECP‐treated lymphocytes can reduce the ability of LPS‐stimulated monocytes to produce some proinflammatory cytokines; however, this effect is not dependent on phosphatidylserine externalization.
Journal ArticleDOI
The ethics of ‘Trials within Cohorts’ (TwiCs): 2nd international symposium
Clare Relton,Maarten Burbach,Clive Collett,James H. Flory,Sophie Gerlich,Søren Holm,Amanda Hunn,Scott Y H Kim,Linda Kwakkenbos,Anne May,Jon Nicholl,Danny Young-Afat,Shaun Treweek,Rudolf Uher,Tjeerd van Staa,Joanne van der Velden,Helena M. Verkooijen,Andrew J. Vickers,Sophie Welch,Merrick Zwarenstein,Scott Y. H. Kim,Zachary Goodman,Anne M. May,Danny A. Young-Afat,J.P.M. Burbach,Carla H. van Gils,Rieke van der Graaf,Helena M. Verkooijen,Laura C. Coates,William Tillett,David J. Torgerson,Neil McHugh,Neil McHugh,Peter C. Taylor,Lesley Brown,Anne Heaven,John Young,Andrew Clegg,Kate Chatfield,Roxanne Gal,Evelyn M. Monninkhof,Danny A. Young Afat,Rolf H.H. Groenwold,Marie-Eve Carrier,Brett D. Thombs,Brett D. Thombs,Joanne M. van der Velden,A. Sophie Gerlich,Jorrit-Jan Verlaan,Alice M. Couwenberg,Johannes P. M. Burbach,Emily Peckham,Suzanne Crossland,Tom Hughes,Alisha O’Connor,Imogen Sargent,Simon Gilbody +56 more
TL;DR: It is possible to make a compelling case to ethics committees that TwiCs designs are appropriate and ethical, and some questions about the ethical requirements for content and timing of informed consent for a study using the TwiC design need to be decided on a case-by-case basis.
Book ChapterDOI
Impact of Comorbidity
Maha Abdul Azeez,Peter C. Taylor +1 more
TL;DR: It is proposed that the development of care plans encompassing a more holistic approach that incorporates comorbidities, rather than focusing on a single disease-orientated model, will greatly improve overall patient survival and quality of life in rheumatic diseases.
Journal ArticleDOI
Clonal analysis of immunoglobulin mRNA in rheumatoid arthritis synovium: characterization of expanded IgG3 populations.
TL;DR: The ratio of replacement/silent somatic mutations in these two families of clones suggests that the selective clonal expansion in the synovium of patients with rheumatoid arthritis is due to an antigen‐driven immune response.